Ayala Pharmaceuticals (ADXS) Competitors

Soligenix (NASDAQ:SNGX) and Ayala Pharmaceuticals (NASDAQ:ADXS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.

Do institutionals and insiders believe in SNGX or ADXS?

3.6% of Soligenix shares are held by institutional investors. Comparatively, 7.2% of Ayala Pharmaceuticals shares are held by institutional investors. 3.1% of Soligenix shares are held by company insiders. Comparatively, 0.6% of Ayala Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has better valuation and earnings, SNGX or ADXS?

Soligenix has higher earnings, but lower revenue than Ayala Pharmaceuticals. Soligenix is trading at a lower price-to-earnings ratio than Ayala Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Soligenix	-$117.03K	-51.88	-$6.14M	-$4.29	-0.43
Ayala Pharmaceuticals	$3.24M	0.45	-$48.07M	-$7.98	0.00

Does the MarketBeat Community favor SNGX or ADXS?

Soligenix received 278 more outperform votes than Ayala Pharmaceuticals when rated by MarketBeat users. Likewise, 72.97% of users gave Soligenix an outperform vote while only 0.00% of users gave Ayala Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Soligenix	Outperform Votes 278 72.97%	Underperform Votes 103 27.03%
Ayala Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 86 100.00%

Is SNGX or ADXS more profitable?

Ayala Pharmaceuticals has a net margin of 0.00% compared to Soligenix's net margin of -1,473.38%. Ayala Pharmaceuticals' return on equity of 0.00% beat Soligenix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Soligenix	-1,473.38%	-223.29%	-74.18%
Ayala Pharmaceuticals	N/A	N/A	N/A

Which has more volatility & risk, SNGX or ADXS?

Soligenix has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, Ayala Pharmaceuticals has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.

Does the media favor SNGX or ADXS?

In the previous week, Soligenix had 3 more articles in the media than Ayala Pharmaceuticals. MarketBeat recorded 4 mentions for Soligenix and 1 mentions for Ayala Pharmaceuticals. Ayala Pharmaceuticals' average media sentiment score of 0.00 beat Soligenix's score of -0.30 indicating that Ayala Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Soligenix	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ayala Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Ayala Pharmaceuticals beats Soligenix on 8 of the 15 factors compared between the two stocks.